咨询与建议

限定检索结果

文献类型

  • 1 篇 期刊文献

馆藏范围

  • 1 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 医学
    • 1 篇 临床医学

主题

  • 1 篇 metabolism
  • 1 篇 targeted
  • 1 篇 immunity

机构

  • 1 篇 aix marseille un...
  • 1 篇 department of bi...
  • 1 篇 center for cance...
  • 1 篇 department of sy...

作者

  • 1 篇 donghai xiong
  • 1 篇 stephen t wong
  • 1 篇 micael hardy
  • 1 篇 mofei huang
  • 1 篇 ming you
  • 1 篇 balaraman kalyan...
  • 1 篇 yian wang
  • 1 篇 zheng yin

语言

  • 1 篇 英文
检索条件"作者=Micael hardy"
1 条 记 录,以下是1-10 订阅
排序:
Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells
收藏 引用
Cancer Communications 2024年 第3期44卷 448-452页
作者: Donghai Xiong Zheng Yin Mofei Huang Yian Wang micael hardy Balaraman Kalyanaraman Stephen T Wong Ming You Center for Cancer Prevention Houston Methodist Neal Cancer CenterHouston Methodist HospitalWeill Cornell MedicineHoustonTexasUSA Department of Systems Medicine and Bioengineering Houston Methodist Cancer CenterHouston Methodist HospitalWeill Cornell MedicineHoustonTexasUSA Aix Marseille Univ Centre Nationaldela Recherche Scientifique(CNRS)Institut de Chimie Radicalaire(ICR)UnitéMixte de Recherche(UMR)7273MarseilleFrance Department of Biophysics Medical College of WisconsinMilwaukeeWisconsinUSA
Dear Editor,Atovaquone(ATO),a mitochondrial inhibitor,has anti-cancer effects[1].Based on ATO,we developed mitochondria-targeted atovaquone(Mito-ATO)that had even stronger anti-tumor efficacy than ATO[2].We syn-thesiz... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论